Real world evidence on the prescribing trends of glucagon-like peptide-1 agonists in UK primary care

Hinton, W, McGovern, A, van Vlymen, J, Munro, N, Whyte, MB and de Lusignan, S (2016) Real world evidence on the prescribing trends of glucagon-like peptide-1 agonists in UK primary care In: Diabetes UK Professional Conference 2016, 2016-03-02 - 2016-03-04, Scottish Exhibition and Conference Centre, Glasgow, 2-4 March 2016.

Preview

PDF (licence) SRI_deposit_agreement.pdf Available under License : See the attached licence file. Download (33kB) | Preview

Abstract

Aim The use of glucagon-like peptide-1 (GLP-1) agonists in type 2 diabetes is increasing. We present a description of their current use and prescribing trends in UK primary care and compare the characteristics of people prescribed GLP-1 agonists with phase 3 trial populations.

Item Type:	Conference or Workshop Item (Conference Poster)
Subjects :	Nutrition
Divisions :	Faculty of Health and Medical Sciences > School of Biosciences and Medicine > Department of Nutritional Sciences
Authors :	Name Email ORCID Hinton, W UNSPECIFIED UNSPECIFIED McGovern, A UNSPECIFIED UNSPECIFIED van Vlymen, J UNSPECIFIED UNSPECIFIED Munro, N UNSPECIFIED UNSPECIFIED Whyte, MB UNSPECIFIED UNSPECIFIED de Lusignan, S UNSPECIFIED UNSPECIFIED
Date :	March 2016
Identification Number :	10.1111/dme.45_13048
Copyright Disclaimer :	© 2016 John Wiley & Sons, Inc. All Rights Reserved.
Related URLs :	Author
Depositing User :	Symplectic Elements
Date Deposited :	18 Oct 2016 10:08
Last Modified :	18 Oct 2016 10:08
URI:	http://epubs.surrey.ac.uk/id/eprint/812480

Actions (login required)

View Item

Downloads